May 4, 2026 04:02PM
May 4, 2026 04:01PM
Apr 27, 2026 04:30PM
Apr 24, 2026 08:00AM
Feb 19, 2026 04:34PM
Feb 19, 2026 04:01PM
Feb 19, 2026 04:01PM Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 12, 2026 04:30PM
Jan 12, 2026 05:00PM
Jan 12, 2026 05:00PM
Oct 30, 2025 04:07PM
Oct 30, 2025 04:01PM
Oct 23, 2025 04:30PM
Aug 6, 2025 04:03PM Travere Therapeutics (TVTX) Tops Q2 EPS by 16c
Aug 6, 2025 04:01PM
Jul 30, 2025 04:30PM
May 1, 2025 04:03PM
May 1, 2025 04:01PM
Apr 24, 2025 04:30PM
Apr 2, 2025 07:04AM
Feb 20, 2025 05:19PM Travere Therapeutics (TVTX) Tops Q4 EPS by 17c
Feb 20, 2025 04:01PM
Feb 13, 2025 04:30PM
Jan 13, 2025 07:00AM
Nov 7, 2024 07:00AM
Oct 31, 2024 07:00AM
Oct 21, 2024 04:30PM
Aug 6, 2024 04:01PM Ligand Reports Second Quarter 2024 Financial Results
Aug 1, 2024 05:37PM
Aug 1, 2024 04:01PM
Jul 25, 2024 04:30PM
May 7, 2024 04:00PM
May 7, 2024 06:20AM
May 6, 2024 04:08PM
May 6, 2024 04:01PM Travere Therapeutics Reports First Quarter 2024 Financial Results
Apr 29, 2024 04:30PM
Feb 27, 2024 07:00AM
Feb 15, 2024 04:08PM
Feb 15, 2024 04:01PM
Feb 8, 2024 04:30PM
Jan 8, 2024 07:00AM
Nov 8, 2023 04:01PM Ligand Reports Third Quarter 2023 Financial Results
Nov 7, 2023 04:23PM
Nov 7, 2023 04:01PM
Oct 24, 2023 04:30PM
Aug 8, 2023 04:01PM
Aug 3, 2023 04:13PM
Aug 3, 2023 04:01PM
Jul 20, 2023 04:30PM Travere Therapeutics to Report Second Quarter 2023 Financial Results
May 4, 2023 05:02PM

1,198,202 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All